St. Jude: Device tax not solely to blame for layoffs

St. Jude Medical's ($STJ) recently announced job cuts and business realignment are designed to save between $50 million and $60 million a year, the same amount the company expects to lose to the incoming medical device tax. But that's just "a coincidence," Executive Vice President John Heinmiller told MassDevice. The cuts were a response to "a lot of different cost pressures" the company is facing, he said. Report

Suggested Articles

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.

AstraZeneca is linking up with DeepMatter, a big data firm focused on achieving reproducibility in chemistry, to help improve its compound synthesis.

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.